Deducing/VBG
Isoform/NN
Abundance/NN
from/IN
Exon/NN
Junction/NN
Microarray/NN
./.
====================
Alternative/JJ
splicing/NN
(/(
AS/JJ
)/)
is/VBZ
an/DT
important/JJ
mechanism/NN
of/IN
producing/VBG
transcriptome/JJ
diversity/NN
and/CC
microarray/NN
techniques/NNS
are/VBP
being/VBG
used/VBN
increasingly/RB
to/TO
monitor/VB
the/DT
splice/NN
variants/NNS
./.
====================
There/EX
exist/VBP
three/CD
types/NNS
of/IN
microarrays/NNS
interrogating/VBG
AS/JJ
events-junction/NN
,/,
exon/NN
,/,
and/CC
tiling/JJ
arrays/NNS
./.
====================
Junction/NN
probes/NNS
have/VBP
the/DT
advantage/NN
of/IN
monitoring/VBG
the/DT
splice/NN
site/NN
directly/RB
./.
====================
Johnson/NN
et/FW
al./FW
,/,
performed/VBN
a/DT
genome-wide/JJ
survey/RB
of/IN
human/JJ
alternative/JJ
pre-mRNA/NN
splicing/NN
with/IN
exon/NN
junction/NN
microarrays/NNS
(/(
Science/NNP
302:2141-2144/CD
,/,
2003/CD
)/)
,/,
which/WDT
monitored/VBD
splicing/NN
at/IN
every/RB
known/VBN
exon-exon/JJ
junctions/NNS
for/IN
more/RBR
than/IN
10,000/CD
multi-exon/JJ
human/JJ
genes/NNS
in/IN
52/CD
tissues/NNS
and/CC
cell/NN
lines/NNS
./.
====================
Here/RB
,/,
we/PRP
describe/VBP
an/DT
algorithm/NN
to/TO
deduce/VB
the/DT
relative/JJ
concentration/NN
of/IN
isoforms/NNS
from/IN
the/DT
junction/NN
array/NN
data/NNS
./.
====================
Non-negative/JJ
Matrix/NN
Factorization/NN
(/(
NMF/NN
)/)
is/VBZ
applied/VBN
to/TO
obtain/VB
the/DT
transcript/NN
structure/NN
inferred/VBD
from/IN
the/DT
expression/NN
data/NNS
./.
====================
Then/RB
we/PRP
choose/VBP
the/DT
transcript/NN
models/NNS
consistent/JJ
with/IN
the/DT
ECgene/NN
model/NN
of/IN
alternative/JJ
splicing/NN
which/WDT
is/VBZ
based/VBN
on/IN
mRNA/NN
and/CC
EST/NN
alignment/NN
./.
====================
The/DT
probe-transcript/NN
matrix/NN
is/VBZ
constructed/VBN
using/VBG
the/DT
NMF-consistent/JJ
ECgene/NN
transcripts/NNS
,/,
and/CC
the/DT
isoform/NN
abundance/NN
is/VBZ
deduced/VBN
from/IN
the/DT
non-negative/JJ
least/JJS
squares/VBZ
(/(
NNLS/NNS
)/)
fitting/VBG
of/IN
experimental/JJ
data/NNS
./.
====================
Our/PRP$
method/NN
can/MD
be/VB
easily/RB
extended/VBD
to/TO
other/JJ
types/NNS
of/IN
microarrays/NNS
with/IN
exon/NN
or/CC
junction/NN
probes/NNS
./.
====================
Microarrays/NNS
are/VBP
increasingly/RB
used/VBN
to/TO
study/VB
alternative/JJ
====================
splicing/NN
recently/RB
./.
====================
The/DT
major/JJ
advantage/NN
is/VBZ
that/DT
splicing/NN
pattern/NN
of/IN
numerous/JJ
exons/NNS
can/MD
be/VB
monitored/VBN
simultaneously/RB
(/(
Shoemaker/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
It/PRP
is/VBZ
the/DT
most/JJS
promising/VBG
technique/NN
that/DT
can/MD
show/VB
the/DT
transcript/NN
variation/NN
due/IN
to/TO
alternative/JJ
splicing/NN
in/IN
various/JJ
tissues/NNS
,/,
developmental/JJ
,/,
and/CC
pathological/JJ
conditions/NNS
(/(
Xu/NNP
et/FW
al./FW
,/,
2002/CD
;/:
Hu/NNP
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
Proper/NN
interpretation/NN
can/MD
give/VB
information/NN
on/IN
transcript/NN
structure/NN
and/CC
expression/NN
pattern/NN
of/IN
genes/NNS
in/IN
an/DT
efficient/JJ
way/NN
./.
====================
However/RB
,/,
there/EX
is/VBZ
no/DT
standard/JJ
in/IN
manufacturing/VBG
arrays/NNS
and/CC
in/IN
interpreting/VBG
the/DT
data/NNS
yet/RB
./.
====================
To/TO
monitor/VB
alternative/JJ
splicing/NN
events/NNS
with/IN
microarray/NN
technique/NN
,/,
one/CD
needs/VBZ
special/JJ
probe/NN
design/NN
that/DT
can/MD
report/VB
whether/IN
specific/JJ
exons/NNS
or/CC
splice/NN
sites/NNS
are/VBP
present/JJ
in/IN
the/DT
transcript/NN
or/CC
not/RB
./.
====================
Arrays/NNS
of/IN
this/DT
type/NN
are/VBP
called/VBN
'splice/NN
arrays/NNS
'/``
and/CC
oligonucleotides/NNS
are/VBP
typically/RB
used/VBN
as/IN
probe/NN
sequences/NNS
./.
====================
Splice/NN
arrays/NNS
can/MD
be/VB
further/RBR
classified/VBN
into/IN
three/CD
sub-groups/NNS
-/:
junction/NN
,/,
exon/NN
,/,
and/CC
tiling/JJ
array/NN
as/IN
shown/VBN
in/IN
Fig/NN
./.
====================
1/CD
./.
====================
Exon/NN
probe/NN
sequences/NNS
are/VBP
part/NN
of/IN
a/DT
single/JJ
exon/NN
,/,
thereby/RB
manifesting/VBG
expression/NN
of/IN
the/DT
corresponding/JJ
exon/NN
./.
====================
Multiple/JJ
probes/NNS
are/VBP
necessary/JJ
to/TO
identify/VB
alternatively/RB
spliced/VBN
exons/NNS
using/VBG
exon/NN
probes/NNS
./.
====================
Its/PRP$
main/JJ
disadvantage/JJ
would/MD
be/VB
that/DT
exact/VBP
splice/NN
sites/NNS
can/MD
not/RB
be/VB
obtained/VBN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
junction/NN
probes/NNS
consist/VBP
of/IN
concatenation/NN
of/IN
two/CD
neighboring/JJ
exons/NNS
./.
====================
Presence/NN
of/IN
each/DT
splice/NN
site/NN
is/VBZ
directly/RB
examined/VBN
and/CC
any/DT
variation/NN
in/IN
the/DT
splice/NN
site/NN
is/VBZ
reflected/VBN
in/IN
the/DT
probe/NN
intensity/NN
./.
====================
However/RB
,/,
the/DT
sequence/NN
composition/NN
is/VBZ
fairly/RB
limited/JJ
since/IN
they/PRP
can/MD
not/RB
be/VB
far/RB
from/IN
the/DT
splice/NN
site/NN
./.
====================
Hybridization/NN
efficiency/NN
might/MD
be/VB
different/JJ
for/IN
each/DT
probe/NN
,/,
which/WDT
is/VBZ
a/DT
difficult/JJ
problem/NN
to/TO
overcome/VB
in/IN
analyzing/VBG
experimental/JJ
result/NN
./.
====================
Recent/JJ
trend/NN
is/VBZ
to/TO
use/VB
both/CC
the/DT
junction/NN
and/CC
exon/NN
probes/NNS
for/IN
reliable/JJ
prediction/NN
of/IN
splice/NN
site/NN
variation/NN
(/(
Pan/NN
et/FW
al./FW
,/,
2004/CD
;/:
Fehlbaum/NNP
et/FW
al./FW
,/,
2005/CD
;/:
Ule/NNP
efa/./FW
,/,
2005/CD
)/)
./.
====================
Tiling/VBG
array/NN
is/VBZ
collection/NN
of/IN
probes/NNS
reflecting/VBG
the/DT
====================
genomic/JJ
map/VBP
./.
====================
Original/JJ
purpose/NN
of/IN
the/DT
tiling/JJ
array/NN
was/VBD
====================
interrogating/VBG
whether/IN
a/DT
specific/JJ
part/NN
of/IN
the/DT
genome/NN
is/VBZ
transcribed/VBN
or/CC
not/RB
./.
====================
Since/IN
it/PRP
is/VBZ
unbiased/VBN
mapping/NN
of/IN
transcription/NN
,/,
it/PRP
can/MD
be/VB
used/VBN
to/TO
monitor/VB
alternative/JJ
splicing/NN
./.
====================
The/DT
main/JJ
problems/NNS
are/VBP
cost/JJ
and/CC
resolution/NN
./.
====================
Researchers/NNS
at/IN
the/DT
Affymetrix/JJ
Inc./NNP
reported/VBD
tiling/VBG
array/NN
experiment/NN
for/IN
chromosomes/NNS
21/CD
and/CC
22/CD
at/IN
35/CD
nt/NNS
./.
====================
resolution/NN
as/IN
early/JJ
as/IN
in/IN
2002/CD
(/(
Kampa/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Their/PRP$
recent/JJ
update/VBP
includes/VBZ
10/CD
chromosomes/NNS
at/IN
5/CD
nt/NN
./.
====================
resolution/NN
(/(
Cheng/NN
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
Even/RB
though/IN
it/PRP
can/MD
not/RB
be/VB
applied/VBN
for/IN
general/JJ
purpose/NN
due/JJ
to/TO
high/JJ
cost/RB
,/,
the/DT
experimental/JJ
data/NNS
can/MD
be/VB
a/DT
reference/NN
point/NN
fortranscription/NN
with/IN
additional/JJ
tissue/NN
data/NNS
./.
====================
Johnson/NN
et/FW
al/JJ
./.
====================
performed/VBN
a/DT
junction/NN
array/NN
experiment/NN
that/DT
covers/VBZ
-10,000/CD
human/JJ
RefSeq/NN
genes/NNS
in/IN
52/CD
tissues/NNS
and/CC
cell/NN
lines/NNS
(/(
Johnson/NN
etal./FW
,/,
2003/CD
)/)
./.
====================
Each/DT
probe/NN
sequence/NN
consists/VBZ
of/IN
36/CD
nucleotides/NNS
from/IN
two/CD
adjacent/JJ
exons/NNS
(/(
last/JJ
18-mer/NN
in/IN
the/DT
preceding/VBG
exon/NN
and/CC
the/DT
first/JJ
18-mer/NN
in/IN
the/DT
following/VBG
exon/NN
)/)
and/CC
a/DT
linker/NN
sequence/NN
./.
====================
Every/RB
exon-exon/JJ
junction/NN
within/IN
RefSeq/NN
is/VBZ
taken/VBN
into/IN
consideration/NN
in/IN
designing/VBG
the/DT
probe/NN
sequences/NNS
./.
====================
Resulting/VBG
hybridization/NN
reflects/VBZ
the/DT
splice-site/NN
variation/NN
owing/VBG
to/TO
AS/JJ
./.
====================
For/IN
example/NN
,/,
exon/NN
skipping/NN
of/IN
the/DT
8-th/NN
exon/NN
produces/VBZ
reduced/VBD
probe/NN
intensity/NN
for/IN
two/CD
adjacent/JJ
probes/NNS
at/IN
donor/NN
and/CC
acceptor/NN
splice/NN
sites/NNS
of/IN
the/DT
exon/NN
8/CD
./.
====================
Even/RB
though/IN
Johnson/NN
etal./FW
,/,
demonstrated/VBD
successfully/RB
that/IN
microarray/NN
could/MD
be/VB
used/VBN
to/TO
study/VB
alternative/JJ
splicing/NN
at/IN
genome-wide/NN
level/NN
,/,
their/PRP$
analysis/NN
is/VBZ
fairly/RB
limited/JJ
in/IN
several/JJ
aspects/NNS
./.
====================
The/DT
most/JJS
important/JJ
drawback/VBP
is/VBZ
that/DT
their/PRP$
interpretation/NN
lacks/VBZ
any/DT
quantitative/JJ
prediction/NN
of/IN
isoform/NN
concentration/NN
./.
====================
They/PRP
intentionally/RB
avoided/VBD
building/VBG
any/DT
transcript/NN
models/NNS
from/IN
the/DT
experimental/JJ
data/NNS
and/CC
just/RB
examined/VBN
if/IN
any/DT
probe/NN
intensity/NN
is/VBZ
below/IN
expectation/NN
,/,
which/WDT
is/VBZ
a/DT
good/JJ
indication/NN
of/IN
alternative/JJ
splicing/NN
event/NN
./.
====================
Predicting/VBG
transcript/NN
structure/NN
and/CC
abundance/NN
for/IN
each/DT
isoform/NN
simultaneously/RB
would/MD
be/VB
the/DT
most/JJS
important/JJ
,/,
but/CC
truly/RB
demanding/VBG
task/NN
in/IN
the/DT
presence/NN
of/IN
experimental/JJ
noise/RB
./.
====================
A/DT
research/NN
group/NN
at/IN
the/DT
Affymetrix/JJ
Inc./NNP
and/CC
the/DT
University/JJ
of/IN
California/NN
at/IN
Santa/NN
Cruz/NN
developed/VBD
a/DT
method/NN
to/TO
determine/VB
the/DT
relative/JJ
abundance/NN
of/IN
known/JJ
splice/NN
variants/NNS
through/IN
a/DT
maximum/JJ
likelihood/NN
estimation/NN
framework/NN
(/(
Wang/NNP
etal./FW
,/,
2003/CD
)/)
./.
====================
Their/PRP$
analysis/NN
assumes/VBZ
that/DT
splice/NN
variants/NNS
and/CC
their/PRP$
gene/NN
structure/NN
present/JJ
in/IN
the/DT
sample/NN
are/VBP
known/VBN
./.
====================
No/DT
attempt/NN
to/TO
detect/VB
any/DT
novel/JJ
splice/NN
variants/NNS
was/VBD
made/VBN
./.
====================
Here/RB
,/,
we/PRP
describe/VBP
an/DT
algorithm/NN
to/TO
deduce/VB
the/DT
relative/JJ
concentration/NN
of/IN
isoforms/NNS
from/IN
the/DT
junction/NN
array/NN
data/NNS
./.
====================
First/RB
,/,
Non-negative/JJ
Matrix/NN
Factorization/NN
(/(
NMF/NN
;/:
Lee/NNP
and/CC
Seung/JJ
,/,
1999/CD
)/)
is/VBZ
applied/VBN
to/TO
obtain/VB
the/DT
transcript/NN
structure/NN
inferred/VBD
from/IN
the/DT
expression/NN
data/NNS
./.
====================
Then/RB
we/PRP
choose/VBP
the/DT
transcript/NN
models/NNS
consistent/JJ
with/IN
the/DT
ECgene/NN
model/NN
of/IN
alternative/JJ
splicing/NN
since/IN
the/DT
transcript/NN
models/NNS
predicted/VBN
from/IN
NMF/NN
are/VBP
often/RB
unreliable/JJ
./.
====================
ECgene/NN
transcripts/NNS
have/VBP
mRNA/NN
or/CC
EST/NN
sequences/NNS
as/IN
a/DT
supporting/VBG
evidence/NN
./.
====================
The/DT
====================
probe-transcript/NN
matrix/NN
is/VBZ
constructed/VBN
using/VBG
the/DT
resulting/VBG
ECgene/NN
transcripts/NNS
and/CC
the/DT
isoform/NN
abundance/NN
is/VBZ
deduced/VBN
from/IN
the/DT
non-negative/JJ
least/JJS
squares/VBZ
(/(
NNLS/NNS
)/)
fitting/VBG
of/IN
experimental/JJ
data/NNS
./.
====================
Our/PRP$
method/NN
takes/VBZ
the/DT
non-negative/JJ
nature/NN
of/IN
concentration/NN
into/IN
account/VBP
explicitly/RB
,/,
which/WDT
gives/VBZ
dramatic/JJ
difference/NN
from/IN
other/JJ
decomposition-based/VBN
methods/NNS
./.
====================
It/PRP
can/MD
be/VB
easily/RB
extended/VBD
to/TO
other/JJ
types/NNS
of/IN
microarrays/NNS
with/IN
exon/NN
or/CC
junction/NN
probes/NNS
(/(
e.g/FW
./.
====================
Affymetrix/JJ
’/CD
s/NNS
exon/NN
chips/NNS
)/)
./.
====================
Johnson/NN
et/FW
al./FW
,/,
's/POS
junction-array/NN
data/NNS
(/(
GSE740/NN
)/)
were/VBD
downloaded/VBN
from/IN
the/DT
GEO/NN
website/JJ
(/(
Gene/NN
Express/NN
====================
Omnibus/RB
,/,
http/NN
:/:
//www.ncbi.nlm.nih.gov/geo/JJ
)/)
./.
====================
It/PRP
contains/VBZ
more/RBR
than/IN
10,000/CD
multi-exon/JJ
human/JJ
genes/NNS
in/IN
52/CD
tissues/NNS
and/CC
cell/NN
lines/NNS
./.
====================
Oligonucleotide/NN
probes/NNS
were/VBD
placed/VBN
at/IN
every/RB
exon-exon/JJ
junction/NN
in/IN
each/DT
transcript/NN
./.
====================
The/DT
data/NNS
covers/VBZ
105,398/CD
probes/NNS
,/,
10,274/CD
genes/NNS
,/,
11,138/CD
GenBank/NN
accession/NN
and/CC
1,646/CD
genomic/JJ
contigs/NNS
./.
====================
Every/RB
probe/NN
sequence/NN
should/MD
be/VB
mapped/VBN
onto/IN
the/DT
splice/NN
junctions/NNS
in/IN
the/DT
ECgene/NN
transcripts/NNS
./.
====================
We/PRP
compared/VBD
the/DT
gene/NN
symbols/NNS
,/,
GenBank/NN
accession/NN
numbers/NNS
,/,
and/CC
explicit/VBP
sequences/NNS
used/VBN
in/IN
GSE740/NN
with/IN
the/DT
ECgene/NN
annotations/NNS
./.
====================
The/DT
resulting/VBG
gene/NN
symbol/NN
,/,
GenBank/NN
accession/NN
,/,
ECgene/NN
ID/NN
,/,
transcript/NN
ID/NN
,/,
exon/NN
number/NN
,/,
and/CC
probe/NN
sequences/NNS
were/VBD
stored/VBN
in/IN
the/DT
MySQL/NN
database/NN
./.
====================
Using/VBG
the/DT
latest/JJS
ECgene/NN
version/NN
1.2/CD
,/,
we/PRP
were/VBD
able/JJ
to/TO
map/VB
95,945/CD
probes/NNS
out/IN
of/IN
105,389/CD
probes/NNS
in/IN
GSE740/NN
./.
====================
Some/DT
RefSeqs/NNS
could/MD
not/RB
be/VB
aligned/VBN
against/IN
the/DT
genome/NN
with/IN
good/JJ
quality/NN
./.
====================
One/CD
subtle/JJ
point/NN
is/VBZ
worth/NN
mentioning/VBG
./.
====================
Johnson/NN
etal./FW
,/,
made/VBD
probes/NNS
for/IN
each/DT
RefSeq/NN
./.
====================
In/IN
other/JJ
words/NNS
,/,
if/IN
a/DT
gene/NN
had/VBD
more/RBR
than/IN
two/CD
RefSeqs/NNS
representing/VBG
splice/NN
variants/NNS
,/,
junction/NN
probe/NN
sequences/NNS
can/MD
be/VB
redundant/JJ
./.
====================
We/PRP
searched/VBD
all/DT
redundant/JJ
probe/NN
sequences/NNS
and/CC
took/VBD
the/DT
average/NN
value/NN
in/IN
the/DT
subsequent/JJ
steps/NNS
./.
====================
Problem/NN
setup/NN
:/:
The/DT
experimental/JJ
data/NNS
can/MD
be/VB
represented/VBN
====================
as/IN
an/DT
expression/NN
matrix/NN
E/NN
whose/WP$
element/NN
E/NN
pt/NN
is/VBZ
the/DT
====================
hybridization/NN
intensity/NN
of/IN
probe/NN
pfor/IN
tissue/NN
t./IN
The/DT
expression/NN
value/NN
for/IN
each/DT
probe/NN
depends/VBZ
on/IN
several/JJ
factors/NNS
including/VBG
isoform/NN
abundance/NN
,/,
isoform/NN
structure/NN
and/CC
probe/NN
affinity/NN
./.
====================
The/DT
relation/NN
can/MD
be/VB
written/VBN
as/IN
====================
Xit/NN
is/VBZ
the/DT
abundance/NN
(/(
i.e/FW
./.
====================
concentration/NN
)/)
of/IN
isoform/NN
//:
in/IN
tissue/NN
t./FW
The/DT
matrix/NN
M/NN
is/VBZ
the/DT
probe-transcript/NN
matrix/NN
whose/WP$
element/NN
M/NN
represents/VBZ
the/DT
presence/NN
of/IN
probe/NN
sequence/NN
====================
p/NN
in/IN
isoform/NN
//:
./.
====================
M/NN
P/NN
i/LS
is/VBZ
1/CD
if/IN
the/DT
probe/NN
sequence/NN
is/VBZ
part/NN
of/IN
====================
mRNA/NN
sequence/NN
for/IN
isoform/NN
//:
./.
====================
In/IN
matrix/NN
representation/NN
,/,
Eq/NN
./.
====================
(/(
1/CD
)/)
can/MD
be/VB
rewritten/VBN
as/IN
====================
(/(
X/NN
)/)
from/IN
the/DT
expression/NN
data/NNS
(/(
E/NN
)/)
./.
====================
This/DT
is/VBZ
not/RB
an/DT
easy/NN
task/NN
since/IN
(/(
i/LS
)/)
we/PRP
do/VBP
not/RB
have/VB
the/DT
full/JJ
catalog/NN
of/IN
transcripts/NNS
(/(
i.e/FW
./.
====================
splice/RB
variants/NNS
)/)
,/,
(/(
ii/LS
)/)
all/DT
parameters/NNS
in/IN
Eq/NN
./.
====================
(/(
2/CD
)/)
are/VBP
non-negative/JJ
./.
====================
Without/IN
the/DT
first/JJ
problem/NN
,/,
the/DT
NNLS/NN
(/(
non-negative/JJ
least/JJS
squares/VBZ
)/)
fitting/VBG
method/NN
or/CC
the/DT
maximum/JJ
likelihood/NN
optimization/NN
(/(
Wang/NNP
etal./FW
,/,
2003/CD
)/)
can/MD
be/VB
used/VBN
to/TO
obtain/VB
the/DT
transcript/NN
abundance/NN
in/IN
various/JJ
tissues/NNS
./.
====================
They/PRP
take/VBP
the/DT
non-negative/JJ
nature/NN
of/IN
abundance/NN
explicitly/RB
./.
====================
Our/PRP$
method/NN
,/,
named/VBN
as/IN
the/DT
“/NN
isoAbundance/NN
”/CD
algorithm/NN
,/,
combines/NNS
NMF/NN
and/CC
NNLS/NN
procedures/NNS
to/TO
obtain/VB
reliable/JJ
transcript/NN
models/NNS
and/CC
their/PRP$
relative/JJ
concentration/NN
in/IN
each/DT
tissue/NN
./.
====================
Fig/NN
./.
====================
3/CD
shows/VBZ
a/DT
brief/JJ
flowchart/NN
of/IN
the/DT
algorithm/NN
./.
====================
Data/NNS
Pre-processing/JJ
:/:
Before/IN
any/DT
data/NNS
processing/NN
,/,
we/PRP
filtered/VBD
bad/NN
or/CC
non-informative/JJ
probes/NNS
./.
====================
Probes/NNS
whose/WP$
mean/JJ
natural/JJ
log/NN
intensities/NNS
across/IN
52/CD
tissues/NNS
were/VBD
less/RBR
than/IN
0.65/CD
or/CC
larger/JJR
than/IN
11/CD
were/VBD
flagged/VBN
as/IN
dark/NN
and/CC
saturated/JJ
,/,
respectively/RB
./.
====================
Probes/NNS
with/IN
constant/JJ
intensity/NN
were/VBD
also/RB
removed/VBD
since/IN
they/PRP
are/VBP
likely/JJ
due/JJ
to/TO
cross­/VB
hybridization/NN
./.
====================
Selection/NN
of/IN
putative/JJ
transcripts/NNS
using/VBG
NMF/NN
:/:
Non-negative/JJ
Matrix/NN
Factorization/NN
was/VBD
applied/VBN
to/TO
solve/VB
Eq/NN
./.
====================
(/(
2/CD
)/)
./.
====================
Original/JJ
version/NN
of/IN
NMF/NN
was/VBD
to/TO
decompose/VB
a/DT
matrix/NN
V/JJ
~/NN
WH/NN
where/WRB
V/JJ
,/,
W/NN
,/,
H/NN
are/VBP
non-negative/JJ
matrices/NNS
(/(
Lee/NNP
and/CC
Seung/JJ
,/,
1999/CD
)/)
./.
====================
This/DT
is/VBZ
exactly/RB
the/DT
same/JJ
situation/NN
as/IN
in/IN
Eq/NN
./.
====================
(/(
2/CD
)/)
./.
====================
Non-negativity/NN
constraint/NN
makes/VBZ
NMF/NN
distinguished/VBN
from/IN
other/JJ
methods/NNS
such/JJ
as/IN
the/DT
principal/JJ
component/NN
analysis/NN
(/(
PCA/NN
)/)
or/CC
NMF/NN
allows/VBZ
a/DT
parts-/JJ
based/VBN
representation/NN
because/IN
only/RB
additive/JJ
combinations/NNS
are/VBP
allowed/VBN
./.
====================
NMF/NN
applied/VBN
to/TO
decompose/VB
the/DT
expression/NN
matrix/NN
E/NN
~/CD
MX/NN
,/,
allows/VBZ
the/DT
extraction/NN
of/IN
hidden/JJ
localized/VBD
patterns/NNS
such/JJ
as/IN
alternative/JJ
splicing/NN
of/IN
exons/NNS
./.
====================
Applying/VBG
NMF/NN
to/TO
the/DT
expression/NN
matrix/NN
of/IN
dimension/NN
(/(
pxt/NN
)/)
,/,
we/PRP
obtain/VBP
two/CD
non-negative/JJ
factors/NNS
./.
====================
Matrix/JJ
W/NN
has/VBZ
size/NN
(/(
px//JJ
)/)
,/,
which/WDT
each/DT
of/IN
the/DT
//JJ
columns/NNS
defining/VBG
the/DT
presence/NN
of/IN
probes/NNS
in/IN
the/DT
isoform/NN
//:
./.
====================
Matrix/JJ
H/NN
has/VBZ
size/NN
(/(
/xf/NN
)/)
,/,
representing/VBG
the/DT
expression/NN
level/NN
of/IN
isoform/NN
//:
in/IN
the/DT
tissue/NN
t./FW
Therefore/RB
W/NN
====================
and/CC
H/NN
are/VBP
equivalent/JJ
to/TO
the/DT
probe-transcript/NN
matrix/NN
M/NN
and/CC
the/DT
transcript/NN
abundance/NN
matrix/NN
X/NN
,/,
respectively/RB
./.
====================
However/RB
,/,
we/PRP
find/VBP
that/IN
NMF/NN
method/NN
has/VBZ
many/JJ
drawbacks/NNS
to/TO
apply/RB
for/IN
the/DT
junction/NN
array/NN
data/NNS
./.
====================
Iterative/JJ
optimization/NN
is/VBZ
not/RB
always/RB
robust/JJ
and/CC
may/MD
fail/VB
occasionally/RB
./.
====================
It/PRP
is/VBZ
also/RB
sensitive/JJ
to/TO
the/DT
experimental/JJ
noise/JJ
./.
====================
NMF/NN
solution/NN
to/TO
Eq/NN
./.
====================
(/(
2/CD
)/)
may/MD
not/RB
be/VB
unique/JJ
-/:
i.e/FW
./.
====================
random/JJ
seeding/VBG
may/MD
give/VB
different/JJ
combinations/NNS
of/IN
W/NN
and/CC
H./NNP
Furthermore/RB
,/,
many/JJ
transcript/NN
models/NNS
inferred/VBD
from/IN
NMF/NN
factorization/NN
have/VBP
unrealistic/JJ
structure/NN
./.
====================
In/IN
an/DT
effort/NN
to/TO
take/VB
these/DT
problems/NNS
into/IN
consideration/NN
,/,
we/PRP
decided/VBD
to/TO
keep/VB
transcripts/NNS
whose/WP$
exon/NN
structure/NN
is/VBZ
consistent/JJ
with/IN
any/DT
ECgene/JJ
models/NNS
./.
====================
Since/IN
ECgene/NN
is/VBZ
based/VBN
on/IN
genomic/JJ
alignment/NN
of/IN
mRNA/NN
and/CC
EST/NN
sequences/NNS
,/,
this/DT
ensures/VBZ
that/DT
each/DT
isoform/NN
model/NN
in/IN
subsequent/JJ
sections/NNS
has/VBZ
supporting/VBG
evidence/NN
of/IN
clones/NNS
./.
====================
We/PRP
simply/RB
examined/VBN
the/DT
absent/JJ
probes/NNS
from/IN
the/DT
NMF-derived/JJ
probe-transcript/NN
matrix/NN
to/TO
test/VB
the/DT
identity/NN
of/IN
NMF/NN
and/CC
ECgene/NN
models/NNS
./.
====================
NNLS/NNS
optimization/NN
to/TO
obtain/VB
isoform/NN
abundance/NN
:/:
The/DT
probe-transcript/NN
matrix/NN
is/VBZ
constructed/VBN
using/VBG
the/DT
resulting/VBG
ECgene/NN
transcripts/NNS
and/CC
the/DT
isoform/NN
abundance/NN
is/VBZ
deduced/VBN
from/IN
the/DT
non-negative/JJ
least/JJS
squares/VBZ
(/(
NNLS/NNS
)/)
fitting/VBG
of/IN
experimental/JJ
data/NNS
./.
====================
NNLS/NNS
method/NN
solves/VBZ
“/CD
Ax=b/NN
”/CD
in/IN
a/DT
least/JJS
squares/VBZ
sense/NN
,/,
under/IN
constraint/JJ
“/CD
vector/NN
x/NN
has/VBZ
non-negative/JJ
elements/NNS
./.
====================
A/DT
is/VBZ
equivalent/JJ
to/TO
the/DT
probe-transcript/NN
matrix/NN
./.
====================
Two/CD
vectors/NNS
(/(
x/NN
and/CC
b/LS
)/)
are/VBP
isoform/NN
abundance/NN
and/CC
its/PRP$
expression/NN
intensity/NN
in/IN
a/DT
specific/JJ
tissue/NN
,/,
essentially/RB
being/VBG
a/DT
column/NN
of/IN
X/NN
and/CC
E/NN
matrices/NNS
,/,
respectively/RB
./.
====================
The/DT
solution/NN
corresponds/VBZ
to/TO
the/DT
relative/JJ
abundance/NN
of/IN
isoforms/NNS
./.
====================
A/DT
subtle/JJ
problem/NN
of/IN
weighting/VBG
arises/VBZ
in/IN
NNLS/NN
fitting/VBG
./.
====================
Since/IN
most/JJS
exons/NNS
are/VBP
constitutive/JJ
(/(
not/RB
showing/VBG
AS/JJ
event/NN
)/)
,/,
there/EX
exist/VBP
only/RB
limited/JJ
number/NN
of/IN
probes/NNS
with/IN
information/NN
on/IN
AS/JJ
events/NNS
./.
====================
It/PRP
is/VBZ
desirable/JJ
to/TO
increase/VB
the/DT
weight/NN
of/IN
those/DT
informative/JJ
(/(
AS-related/JJ
)/)
probes/NNS
./.
====================
For/IN
simplicity/NN
,/,
we/PRP
substituted/VBD
all/DT
constitutive/JJ
probes/NNS
with/IN
a/DT
hypothetical/JJ
probe/NN
whose/WP$
expression/NN
was/VBD
just/RB
the/DT
average/NN
value/NN
./.
====================
This/DT
allows/VBZ
that/DT
NNLS/NN
algorithm/NN
sensitively/RB
picks/NNS
up/IN
the/DT
variation/NN
in/IN
isoform/NN
abundance/NN
./.
====================
We/PRP
applied/VBD
our/PRP$
method/NN
to/TO
three/CD
genes/NNS
(/(
OCRL1/NN
,/,
HMGCR/NN
,/,
and/CC
APP/NN
)/)
whose/WP$
RT-PCR/NN
and/CC
sequencing/NN
results/NNS
were/VBD
reported/VBN
by/IN
Johnson/NN
et/FW
al./FW
,/,
For/IN
these/DT
case/NN
studies/NNS
,/,
we/PRP
used/VBD
the/DT
ECgene/NN
transcripts/NNS
whose/WP$
gene/NN
structure/NN
is/VBZ
the/DT
same/JJ
with/IN
those/DT
in/IN
the/DT
Johnson/NN
et/FW
al/JJ
./.
====================
's/POS
paper/NN
./.
====================
OCRL1/NN
gene/NN
is/VBZ
known/VBN
to/TO
have/VB
two/CD
isoforms/NNS
as/IN
shown/VBN
in/IN
Fig/NN
./.
====================
4A/CD
./.
====================
Long/JJ
isoform/NN
(/(
NM_000276/NN
)/)
is/VBZ
expressed/VBN
in/IN
retina/NN
and/CC
fetal/JJ
brain/NN
,/,
whereas/IN
a/DT
short/JJ
form/NN
(/(
NM_001587/NN
)/)
====================
is/VBZ
observed/VBN
in/IN
kidney/NN
that/DT
lacks/VBZ
a/DT
24-nt/JJ
./.
====================
exon/NN
./.
====================
They/PRP
confirmed/VBD
the/DT
expectation/NN
from/IN
junction/NN
array/NN
data/NNS
with/IN
RT-PCR/NN
experiment/NN
and/CC
sequencing/NN
./.
====================
Our/PRP$
result/NN
agrees/NNS
well/RB
with/IN
the/DT
experimental/JJ
result/NN
./.
====================
The/DT
intersection/NN
of/IN
gene/NN
model/NN
from/IN
the/DT
NMF/NN
and/CC
the/DT
ECgene/NN
transcripts/NNS
found/VBN
2/CD
isoforms/NNS
./.
====================
Variant/JJ
#/CD
2/CD
and/CC
#/NN
3/CD
correspond/VBP
to/TO
NM_000276/NN
and/CC
NM_001587/NN
,/,
respectively/RB
./.
====================
Table/JJ
1/CD
shows/VBZ
the/DT
summary/NN
of/IN
our/PRP$
algorithm/NN
./.
====================
Long/JJ
isoform/NN
is/VBZ
expressed/VBN
in/IN
all/DT
three/CD
tissues/NNS
,/,
whereas/IN
the/DT
short/JJ
one/CD
is/VBZ
pre-dominant/JJ
form/VBP
in/IN
kidney/NN
and/CC
fetal/JJ
brain/NN
./.
====================
Johnson/NN
et/FW
al./FW
,/,
also/RB
showed/VBD
that/IN
the/DT
junction/NN
array/NN
data/NNS
could/MD
predict/VB
novel/JJ
isoforms/NNS
for/IN
the/DT
case/NN
of/IN
HMGCR/NN
gene/NN
./.
====================
Only/RB
one/CD
isoform/NN
was/VBD
known/VBN
at/IN
that/DT
point/VBP
./.
====================
Their/PRP$
junction/NN
array/NN
data/NNS
clearly/RB
indicated/VBD
alternative/JJ
splicing/NN
of/IN
the/DT
13-th/NN
exon/NN
as/IN
indicated/VBD
in/IN
Fig/NN
./.
====================
4B/NN
./.
====================
Their/PRP$
RT-PCR/NN
result/NN
for/IN
this/DT
gene/NN
showed/VBD
two/CD
bands/NNS
in/IN
most/JJS
of/IN
the/DT
44/CD
tissues/NNS
./.
====================
Our/PRP$
analysis/NN
predicted/VBD
that/DT
two/CD
isoforms/NNS
were/VBD
present/JJ
in/IN
46/CD
tissues/NNS
out/RP
of/IN
52/CD
tissue/NN
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
Furthermore/RB
,/,
NMF/NN
and/CC
ECgene/NN
suggest/VBP
another/DT
novel/JJ
transcript/NN
with/IN
different/JJ
first/JJ
exon/NN
(/(
isoform/NN
#/CD
1/CD
)/)
./.
====================
The/DT
reality/NN
of/IN
this/DT
isoform/NN
should/MD
be/VB
====================
Case/NN
study/NN
on/IN
the/DT
APP/NN
gene/NN
is/VBZ
rather/RB
complicated/VBN
./.
====================
Johnson/NN
etal./FW
,/,
found/VBN
that/IN
it/PRP
had/VBD
three/CD
isoforms/NNS
shown/VBN
in/IN
Fig/NN
./.
====================
4C/NN
./.
====================
Two/CD
isoforms/NNS
(/(
NM_000484/CD
and/CC
X06989/NN
)/)
are/VBP
present/JJ
in/IN
most/JJS
nonneuronal/JJ
samples/NNS
,/,
e.g./FW
,/,
melanoma/NN
and/CC
lung/NN
carcinoma/NN
./.
====================
Exon/NN
8/CD
of/IN
NM_000484/NN
is/VBZ
frequently/RB
missing/VBG
in/IN
all/DT
brain/NN
tissues/NNS
(/(
X06989/CD
)/)
./.
====================
Additional/JJ
exon/NN
7/CD
of/IN
NM_000484/NN
is/VBZ
skipped/VBN
in/IN
fetal/JJ
brain/NN
tissue/NN
(/(
Y00264/NN
)/)
./.
====================
Our/PRP$
analysis/NN
in/IN
Table/JJ
2/CD
seems/VBZ
substantially/RB
different/JJ
from/IN
their/PRP$
result/NN
./.
====================
NMF/NN
and/CC
ECgene/NN
suggested/VBD
a/DT
novel/JJ
isoform/NN
which/WDT
is/VBZ
exactly/RB
the/DT
same/JJ
with/IN
NM_000484/NN
except/IN
the/DT
first/JJ
exon/NN
./.
====================
This/DT
can/MD
happen/VB
if/IN
the/DT
probe/NN
intensity/NN
for/IN
the/DT
junction/NN
between/IN
the/DT
first/JJ
and/CC
second/JJ
====================
exons/NNS
of/IN
NM_000484/NN
is/VBZ
low/JJ
compared/VBN
to/TO
other/JJ
constitutive/JJ
probes/NNS
./.
====================
It/PRP
remains/VBZ
to/TO
be/VB
seen/VBN
if/IN
this/DT
new/JJ
isoform/NN
is/VBZ
real/JJ
or/CC
it/PRP
should/MD
be/VB
regarded/VBN
as/IN
equivalent/JJ
to/TO
the/DT
RefSeq/NN
NM_000484/NN
./.
====================
Results/NNS
for/IN
melanoma/NN
and/CC
lung/NN
carcinoma/NN
do/VBP
not/RB
agree/VB
well/RB
with/IN
the/DT
RT-PCR/NN
result/NN
./.
====================
The/DT
APP/NN
case/NN
clearly/RB
indicates/VBZ
that/IN
our/PRP$
algorithm/NN
requires/VBZ
some/DT
improvements/NNS
./.
====================
There/EX
are/VBP
many/JJ
factors/NNS
to/TO
take/VB
into/IN
consideration/NN
./.
====================
Different/JJ
hybridization/NN
efficiency/NN
of/IN
junction/NN
probes/NNS
is/VBZ
the/DT
most/JJS
serious/JJ
problem/NN
./.
====================
Conventional/JJ
probe/NN
sequences/NNS
are/VBP
designed/VBN
to/TO
have/VB
similar/JJ
melting/VBG
temperatures/NNS
./.
====================
Since/IN
junction/NN
probes/NNS
have/VBP
limited/VBN
freedom/JJ
of/IN
sequence/NN
selection/NN
,/,
their/PRP$
hybridization/NN
efficiency/NN
may/MD
be/VB
vastly/RB
different/JJ
./.
====================
Method/NN
to/TO
estimate/VB
hybridization/NN
efficiency/NN
for/IN
each/DT
probe/NN
is/VBZ
essential/JJ
for/IN
successful/JJ
interpretation/NN
of/IN
junction/NN
array/NN
data/NNS
./.
====================
Observed/JJ
probe/NN
intensities/VBZ
for/IN
constitutive/JJ
exons/NNS
could/MD
give/VB
some/DT
idea/NN
on/IN
different/JJ
hybridization/NN
efficiency/NN
of/IN
each/DT
probe/NN
./.
====================
Matrix/NN
W/NN
from/IN
NMF/NN
calculation/NN
should/MD
reflect/VB
the/DT
hybridization/NN
efficiency/NN
too/RB
in/IN
ideal/JJ
situation/NN
./.
====================
One/CD
can/MD
calculate/VB
the/DT
====================
melting/VBG
temperature/NN
from/IN
the/DT
probe/NN
sequence/NN
and/CC
may/MD
be/VB
able/JJ
to/TO
estimate/VB
the/DT
hybridization/NN
efficiency/NN
theoretically/RB
./.
====================
One/CD
of/IN
these/DT
methods/NNS
or/CC
an/DT
entirely/RB
different/JJ
approach/NN
is/VBZ
imperative/JJ
to/TO
overcome/VB
the/DT
problem/NN
of/IN
different/JJ
hybridization/NN
efficiency/NN
in/IN
junction/NN
or/CC
exon/NN
array/NN
data/NNS
./.
====================
Another/DT
critical/JJ
step/NN
is/VBZ
the/DT
proper/JJ
selection/NN
of/IN
isoforms/NNS
./.
====================
Almost/RB
all/DT
methods/NNS
analyzing/VBG
splice/NN
array/NN
data/NNS
predict/VBP
alternative/JJ
splicing/NN
at/IN
the/DT
exon/NN
level/NN
./.
====================
For/IN
example/NN
,/,
they/PRP
can/MD
predict/VB
a/DT
specific/JJ
event/NN
of/IN
exon/NN
skipping/NN
fairly/RB
accurately/RB
./.
====================
However/RB
,/,
concurrent/JJ
events/NNS
at/IN
several/JJ
exons/NNS
should/MD
be/VB
correlated/VBN
to/TO
predict/VB
gene/NN
expression/NN
at/IN
the/DT
isoform/NN
level/NN
./.
====================
It/PRP
would/MD
be/VB
quite/RB
challenging/JJ
since/IN
both/CC
AS/JJ
and/CC
different/JJ
hybridization/NN
affects/VBZ
the/DT
probe/NN
intensities/VBZ
simultaneously/RB
./.
====================
No/DT
method/NN
is/VBZ
advanced/JJ
enough/IN
to/TO
deduce/VB
the/DT
transcript/NN
structure/NN
from/IN
the/DT
microarray/NN
data/NNS
yet/RB
./.
====================
An/DT
iterative/JJ
procedure/NN
that/DT
learns/VBZ
the/DT
hybridization/NN
affinity/NN
and/CC
AS/JJ
events/NNS
alternately/RB
may/MD
be/VB
developed/VBN
to/TO
solve/VB
this/DT
problem/NN
./.
====================
The/DT
problem/NN
of/IN
isoform/NN
selection/NN
can/MD
be/VB
alleviated/VBN
as/IN
====================
the/DT
catalog/NN
of/IN
splice/NN
variants/NNS
becomes/VBZ
more/RBR
complete/JJ
./.
====================
RefSeq/NN
and/CC
Ensembl/NN
are/VBP
the/DT
two/CD
main/JJ
resources/NNS
for/IN
gene/NN
structure/NN
./.
====================
Databases/NNS
focused/VBN
on/IN
alternative/JJ
splicing/NN
comprise/VBP
the/DT
ASD/NN
,/,
AceView/NN
and/CC
ECgene/NN
./.
====================
Adjusting/VBG
weights/NNS
for/IN
constitutive/JJ
and/CC
alternative/JJ
exons/NNS
might/MD
be/VB
helpful/JJ
to/TO
emphasize/VB
the/DT
effect/NN
of/IN
AS/JJ
in/IN
the/DT
NNLS/NN
fitting/VBG
step/NN
./.
====================
Recently/RB
,/,
several/JJ
labs/NNS
are/VBP
trying/VBG
to/TO
identify/VB
AS/JJ
events/NNS
using/VBG
the/DT
so-called/JJ
splice/NN
array/NN
that/DT
contains/VBZ
junction/NN
,/,
exon/NN
and/CC
intron/NN
intron/NN
probes/NNS
for/IN
a/DT
single/JJ
splice/NN
event/NN
(/(
Pan/NN
etal./FW
,/,
2004/CD
;/:
Fehlbaum/NNP
etal./FW
,/,
2005/CD
;/:
Ule/NNP
etal./FW
,/,
2005/CD
)/)
./.
====================
Notably/RB
,/,
Shai/NNP
etal./FW
,/,
developed/VBD
GenASAP/NN
that/DT
predicted/VBN
the/DT
levels/NNS
of/IN
AS/JJ
and/CC
the/DT
hybridization/NN
profiles/NNS
simultaneously/RB
using/VBG
Bayesian/JJ
learning/VBG
in/IN
an/DT
unsupervised/JJ
probability/NN
model/NN
(/(
Shai/NNP
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
Even/RB
though/IN
it/PRP
is/VBZ
limited/JJ
to/TO
detect/VB
exon/NN
skipping/NN
events/NNS
only/RB
,/,
its/PRP$
ability/NN
to/TO
learn/VB
the/DT
hybridization/NN
affinity/NN
may/MD
be/VB
applied/VBN
to/TO
augment/VB
the/DT
NMF/NN
method/NN
./.
====================
We/PRP
developed/VBD
an/DT
algorithm/NN
that/DT
predicts/VBZ
the/DT
isoform/NN
abundance/NN
from/IN
the/DT
junction/NN
array/NN
data/NNS
./.
====================
Unlike/IN
other/JJ
algorithms/NNS
dealing/VBG
with/IN
individual/JJ
AS/JJ
event/NN
at/IN
the/DT
exon/NN
level/NN
,/,
our/PRP$
method/NN
uses/VBZ
the/DT
NMF/NN
algorithm/NN
to/TO
obtain/VB
the/DT
transcript/NN
models/NNS
consistent/JJ
with/IN
the/DT
ECgene/NN
prediction/NN
./.
====================
Then/RB
the/DT
relative/JJ
isoform/NN
abundance/NN
is/VBZ
deduced/VBN
from/IN
the/DT
NNLS/NN
fitting/VBG
of/IN
expression/NN
data/NNS
./.
====================
Recent/JJ
development/NN
of/IN
human/JJ
exon/NN
chips/NNS
from/IN
the/DT
Affymetrix/JJ
Inc./NNP
provides/VBZ
an/DT
exciting/VBG
opportunity/NN
to/TO
examine/VB
transcription/NN
at/IN
the/DT
exon/NN
level/NN
on/IN
the/DT
genome-wide/NN
scale/NN
./.
====================
It/PRP
contains/VBZ
~1.4/CD
million/NN
probes/NNS
that/DT
comprising/VBG
-4/CD
probes/exon/NN
and/CC
-40/CD
probes/gene/NN
on/IN
average/NN
./.
====================
Methods/NNS
to/TO
analyze/VB
such/JJ
type/NN
of/IN
data/NNS
are/VBP
urgently/RB
needed/VBD
./.
====================
Our/PRP$
method/NN
can/MD
be/VB
easily/RB
extended/VBD
to/TO
other/JJ
types/NNS
of/IN
microarrays/NNS
with/IN
exon/NN
and/CC
junction/NN
probes/NNS
./.
====================
It/PRP
is/VBZ
just/RB
a/DT
matter/NN
of/IN
defining/VBG
the/DT
probe-transcript/NN
matrix/NN
according/VBG
to/TO
the/DT
probe/NN
position/NN
in/IN
the/DT
transcript/NN
structure/NN
./.
====================
However/RB
,/,
it/PRP
should/MD
be/VB
pointed/VBN
out/RP
that/DT
the/DT
catalog/NN
of/IN
splice/NN
variants/NNS
is/VBZ
not/RB
complete/JJ
even/RB
with/IN
today/JJ
’/CD
s/NNS
vast/JJ
amount/NN
of/IN
mRNA/NN
and/CC
EST/NN
sequences/NNS
in/IN
the/DT
GenBank/NN
./.
====================
Methods/NNS
that/DT
take/VBP
the/DT
differential/JJ
hybridization/NN
efficiency/NN
and/CC
identification/NN
of/IN
novel/JJ
splice/NN
variants/NNS
into/IN
account/VBP
simultaneously/RB
should/MD
be/VB
developed/VBN
in/IN
the/DT
near/JJ
future/JJ
./.
====================
